Solara Active Pharma Sciences has informed that pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) and Regulation 10(c) of Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, (‘SEBI SBEB & SE Regulations’), the Board of Directors have approved the allotment of 2,200 Equity Shares of face value Rs 10 each fully paid up against the exercise of vested Options of Solara Employee Stock Option Plan 2018. The equity shares so allotted under the aforesaid Scheme, shall rank with the existing equity shares of the Company in all respects. Consequent to the aforesaid allotment, the paid?up share capital of the Company will accordingly increase, as details enclosed. In terms of Regulation 10(c) read with Part - E of the SEBI SBEB & SE Regulations, the details of the shares allotted are enclosed as ‘Annexure-A; and the details required as per Master circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as ‘Annexure -B’.
The above information is a part of company’s filings submitted to BSE.
